QQQ   295.55 (+0.75%)
AAPL   146.26 (+1.60%)
MSFT   248.43 (+0.17%)
META   151.16 (+2.62%)
GOOGL   99.22 (+1.74%)
AMZN   102.12 (+2.92%)
TSLA   173.34 (+8.15%)
NVDA   201.13 (+1.57%)
NIO   12.36 (+1.56%)
BABA   117.76 (-2.33%)
AMD   75.72 (+0.75%)
T   19.89 (-0.55%)
MU   63.21 (+0.65%)
F   13.14 (+1.70%)
CGC   2.87 (+3.99%)
GE   83.35 (+2.72%)
DIS   109.79 (+0.08%)
AMC   5.18 (-1.89%)
PFE   44.09 (-0.36%)
PYPL   81.83 (+1.26%)
NFLX   362.87 (-0.55%)
QQQ   295.55 (+0.75%)
AAPL   146.26 (+1.60%)
MSFT   248.43 (+0.17%)
META   151.16 (+2.62%)
GOOGL   99.22 (+1.74%)
AMZN   102.12 (+2.92%)
TSLA   173.34 (+8.15%)
NVDA   201.13 (+1.57%)
NIO   12.36 (+1.56%)
BABA   117.76 (-2.33%)
AMD   75.72 (+0.75%)
T   19.89 (-0.55%)
MU   63.21 (+0.65%)
F   13.14 (+1.70%)
CGC   2.87 (+3.99%)
GE   83.35 (+2.72%)
DIS   109.79 (+0.08%)
AMC   5.18 (-1.89%)
PFE   44.09 (-0.36%)
PYPL   81.83 (+1.26%)
NFLX   362.87 (-0.55%)
QQQ   295.55 (+0.75%)
AAPL   146.26 (+1.60%)
MSFT   248.43 (+0.17%)
META   151.16 (+2.62%)
GOOGL   99.22 (+1.74%)
AMZN   102.12 (+2.92%)
TSLA   173.34 (+8.15%)
NVDA   201.13 (+1.57%)
NIO   12.36 (+1.56%)
BABA   117.76 (-2.33%)
AMD   75.72 (+0.75%)
T   19.89 (-0.55%)
MU   63.21 (+0.65%)
F   13.14 (+1.70%)
CGC   2.87 (+3.99%)
GE   83.35 (+2.72%)
DIS   109.79 (+0.08%)
AMC   5.18 (-1.89%)
PFE   44.09 (-0.36%)
PYPL   81.83 (+1.26%)
NFLX   362.87 (-0.55%)
QQQ   295.55 (+0.75%)
AAPL   146.26 (+1.60%)
MSFT   248.43 (+0.17%)
META   151.16 (+2.62%)
GOOGL   99.22 (+1.74%)
AMZN   102.12 (+2.92%)
TSLA   173.34 (+8.15%)
NVDA   201.13 (+1.57%)
NIO   12.36 (+1.56%)
BABA   117.76 (-2.33%)
AMD   75.72 (+0.75%)
T   19.89 (-0.55%)
MU   63.21 (+0.65%)
F   13.14 (+1.70%)
CGC   2.87 (+3.99%)
GE   83.35 (+2.72%)
DIS   109.79 (+0.08%)
AMC   5.18 (-1.89%)
PFE   44.09 (-0.36%)
PYPL   81.83 (+1.26%)
NFLX   362.87 (-0.55%)
NYSE:MCK

McKesson - MCK Stock Forecast, Price & News

$384.01
-0.11 (-0.03%)
(As of 01/27/2023 12:34 PM ET)
Add
Compare
Today's Range
$381.56
$387.57
50-Day Range
$368.28
$386.85
52-Week Range
$250.64
$401.78
Volume
240,604 shs
Average Volume
877,817 shs
Market Capitalization
$54.45 billion
P/E Ratio
27.10
Dividend Yield
0.56%
Price Target
$411.20

McKesson MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
7.1% Upside
$411.20 Price Target
Short Interest
Healthy
2.49% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.49mentions of McKesson in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$6.13 M Sold Last Quarter
Proj. Earnings Growth
6.38%
From $24.78 to $26.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Medical Sector

218th out of 1,055 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 7 stocks


MCK stock logo

About McKesson (NYSE:MCK) Stock

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Stock News Headlines

ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
McKesson (MCK) Stock Moves -1.32%: What You Should Know
4 Stocks You Should Be Eager to Buy in 2023
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
McKesson (MCK) Flat As Market Sinks: What You Should Know
Boring Was King of Healthcare in 2022
Buy This Warren Buffett-Owned Stock for 2023 and Beyond
12 Best Performing Dividend Stocks in 2022
LabCorp's (LH) New APH Lab to Expand Global Capabilities
Masimo (MASI) W1 Watch With Hi to Improve Patient Outcome
See More Headlines
Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Company Calendar

Last Earnings
11/01/2022
Ex-Dividend for 1/3 Dividend
11/30/2022
Dividend Payable
1/03/2023
Today
1/27/2023
Next Earnings (Confirmed)
2/01/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
58155Q10
Employees
75,000
Year Founded
1833

Price Target and Rating

Average Stock Price Forecast
$411.20
High Stock Price Forecast
$445.00
Low Stock Price Forecast
$376.00
Forecasted Upside/Downside
+7.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Net Income
$1.11 billion
Pretax Margin
1.17%

Debt

Sales & Book Value

Annual Sales
$263.97 billion
Cash Flow
$32.22 per share
Book Value
($12.33) per share

Miscellaneous

Free Float
141,495,000
Market Cap
$54.45 billion
Optionable
Optionable
Beta
0.63

Social Links


Key Executives

  • Mr. Brian S. Tyler Ph.D.Mr. Brian S. Tyler Ph.D. (Age 56)
    CEO & Director
    Comp: $5.9M
  • Mr. Britt J. VitaloneMr. Britt J. Vitalone (Age 54)
    Exec. VP & CFO
    Comp: $2.63M
  • Ms. Nancy Avila (Age 56)
    Exec. VP, Chief Information Officer & CTO
    Comp: $1.6M
  • Ms. Lori A. Schechter J.D.Ms. Lori A. Schechter J.D. (Age 61)
    Exec. VP, Chief Legal Officer & Gen. Counsel
    Comp: $2.66M
  • Mr. Napoleon B. Rutledge Jr. (Age 51)
    Sr. VP, Controller & Chief Accounting Officer
  • Ms. Holly Weiss
    Sr. VP of Investor Relations
  • Mr. Pete Slone
    Sr. VP of Corp. Public Affairs
  • Ms. LeAnn B. Smith
    Exec. VP & Chief HR Officer
  • Mr. Kirk Kaminsky
    Pres of The US Pharmaceutical & Specialty Solutions Bus.
  • Paul A. Smith
    Sr. VP of Taxes













MCK Stock - Frequently Asked Questions

Should I buy or sell McKesson stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MCK shares.
View MCK analyst ratings
or view top-rated stocks.

What is McKesson's stock price forecast for 2023?

9 brokerages have issued 12-month target prices for McKesson's shares. Their MCK share price forecasts range from $376.00 to $445.00. On average, they predict the company's share price to reach $411.20 in the next year. This suggests a possible upside of 7.0% from the stock's current price.
View analysts price targets for MCK
or view top-rated stocks among Wall Street analysts.

How have MCK shares performed in 2023?

McKesson's stock was trading at $375.12 at the beginning of the year. Since then, MCK shares have increased by 2.4% and is now trading at $384.12.
View the best growth stocks for 2023 here
.

Are investors shorting McKesson?

McKesson saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 3,520,000 shares, a decline of 8.8% from the December 31st total of 3,860,000 shares. Based on an average daily volume of 1,070,000 shares, the short-interest ratio is presently 3.3 days. Currently, 2.5% of the company's shares are short sold.
View McKesson's Short Interest
.

When is McKesson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our MCK earnings forecast
.

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Wednesday, February 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) released its quarterly earnings data on Tuesday, November, 1st. The company reported $6.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.13 by $0.07. The business earned $70.16 billion during the quarter, compared to the consensus estimate of $69.66 billion. McKesson had a net margin of 0.76% and a negative trailing twelve-month return on equity of 267.09%.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, January 26th. Stockholders of record on Wednesday, March 1st will be paid a dividend of $0.54 per share on Monday, April 3rd. This represents a $2.16 annualized dividend and a yield of 0.56%.
Read our dividend analysis for MCK
.

Is McKesson a good dividend stock?

McKesson (NYSE:MCK) pays an annual dividend of $2.16 per share and currently has a dividend yield of 0.57%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 15.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MCK will have a dividend payout ratio of 8.19% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MCK.

How will McKesson's stock buyback program work?

McKesson announced that its board has initiated a stock repurchase plan on Tuesday, February 2nd 2021, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 6.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY 2023 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $24.45-$24.95 for the period, compared to the consensus EPS estimate of $24.50. The company issued revenue guidance of $271.88 billion-$282.44 billion, compared to the consensus revenue estimate of $276.54 billion.

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson Chief Executive Officer Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among the company's employees.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by many different retail and institutional investors. Top institutional shareholders include Strs Ohio (0.22%), Artemis Investment Management LLP (0.16%), Meyer Handelman Co. (0.10%), Signature Estate & Investment Advisors LLC (0.07%), Wedge Capital Management L L P NC (0.07%) and Ardevora Asset Management LLP (0.05%). Insiders that own company stock include Brian S Tyler, Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Nancy Flores, Sundeep G Reddy, Sundeep G Reddy, Thomas L Rodgers, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends
.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $384.12.

How much money does McKesson make?

McKesson (NYSE:MCK) has a market capitalization of $54.47 billion and generates $263.97 billion in revenue each year. The company earns $1.11 billion in net income (profit) each year or $14.17 on an earnings per share basis.

How many employees does McKesson have?

The company employs 75,000 workers across the globe.

Does McKesson have any subsidiaries?
The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Echo, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson Europe Holdings GmbH & Co. KGaA, McKesson Global Procurement & Sourcing Limited, McKesson International Bermuda IP2A Limited, McKesson International Bermuda IP3A Limited, McKesson Ireland Limited, McKesson Medical-Surgical Holdings Inc., McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLP, McKesson Medical-Surgical Top Holdings Inc., McKesson Plasma and Biologics LLC, McKesson Specialty Care Distribution LLC, McKesson UK Finance I Limited, McKesson UK Finance II Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., US Oncology Inc., United Drug (Wholesale) Limited, United Drug Distributors Ireland Limited, Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.
Read More
How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The official website for the company is www.mckesson.com. The company can be reached via phone at (972) 446-4800, via email at investors@mckesson.com, or via fax at 415-983-8453.

This page (NYSE:MCK) was last updated on 1/27/2023 by MarketBeat.com Staff